OptimizeRx Corporation
OPRX
$16.94
-$0.313-1.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 33.14% | -32.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 33.14% | -32.15% | |||
| Cost of Revenue | 23.02% | -16.60% | |||
| Gross Profit | 39.65% | -39.41% | |||
| SG&A Expenses | 0.06% | -16.95% | |||
| Depreciation & Amortization | -1.83% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.17% | -16.18% | |||
| Operating Income | 250.85% | -158.17% | |||
| Income Before Tax | 152.16% | -248.73% | |||
| Income Tax Expenses | 116.68% | -147.46% | |||
| Earnings from Continuing Operations | 169.67% | -2,719.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 169.67% | -2,719.23% | |||
| EBIT | 250.85% | -158.17% | |||
| EBITDA | 452.09% | -122.84% | |||
| EPS Basic | 169.52% | -2,735.71% | |||
| Normalized Basic EPS | 152.03% | -248.33% | |||
| EPS Diluted | 166.67% | -2,757.14% | |||
| Normalized Diluted EPS | 150.68% | -248.33% | |||
| Average Basic Shares Outstanding | 0.22% | 0.28% | |||
| Average Diluted Shares Outstanding | 2.95% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||